Tower Research Capital (TRC)’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Tower Research Capital (TRC)’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-23	Closed	-$1K	–	5240
2020 Q2	$1K	Sell	23 -8	-26%	-$284	﹤0.01%	4676
2020 Q1	$1K	Buy	31 +25	+417%	+$871	﹤0.01%	2897
2019 Q4	$0	Sell	6 -33	-85%	-$986	﹤0.01%	4667
2019 Q3	$1K	Sell	39 -1,406	-97%	-$31.8K	﹤0.01%	3975
2019 Q2	$31K	Sell	1,445 -990	-41%	-$20K	﹤0.01%	1894
2019 Q1	$41K	Sell	2,435 -181	-7%	-$2.71K	﹤0.01%	1871
2018 Q4	$30K	Buy	2,616 +1,576	+152%	+$20.7K	﹤0.01%	1639
2018 Q3	$17K	Buy	1,040 +533	+105%	+$8.05K	﹤0.01%	2463
2018 Q2	$6K	Sell	507 -784	-61%	-$11.9K	﹤0.01%	3028
2018 Q1	$19K	Buy	+1,291	New	+$20K	﹤0.01%	2206

Other funds holding ZEAL

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tower Research Capital (TRC)'s ZEAL Position: Q3 2020 in Review

Tower Research Capital (TRC) sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2020, closing a stake of 23 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in ZEAL in Q1 2018 and held it in 10 quarters. The position peaked at $41K in Q1 2019. 14 funds tracked by Wall St. Rank hold ZEAL as of Q3 2020.

Tower Research Capital (TRC) reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Tower Research Capital (TRC) sold 23 Zealand Pharma A/S American Depositary Shares shares in Q3 2020, an estimated $1K.
Tower Research Capital (TRC) first reported a position in Zealand Pharma A/S American Depositary Shares in Q1 2018 and held it in 10 quarters.
Tower Research Capital (TRC)'s Zealand Pharma A/S American Depositary Shares position peaked at $41K in Q1 2019.
14 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2020.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.